Abiopharma

(99% Neutral) Cidara Therapeutics, Inc. (CDTX) Announces Business Combination

Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

New Form SC 14D9/A - Cidara Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005515 Size: 17 KB

(30% Negative) ORAMED PHARMACEUTICALS INC. (ORMP) Announces Delay in scheduled Trials for Scilex products Due to Regulatory Process

New Form SC TO-T/A - Cidara Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005513 Size: 46 KB

Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments

Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics

Landmark Study Finds PreTRM® Blood Test Reduces Earliest Preterm Births and Newborn Complications

Sensus Healthcare Appoints Larry Biscotti to its Board of Directors

(99% Neutral) PROCESSA PHARMACEUTICALS, INC. (PCSA) Announces Update on Collaboration with PROCESSA PHARMACEUTICALS

(30% Negative) SAB BIOTHERAPEUTICS, INC. (SABSW) Announces Delay in confidence Trials for advancing innov Due to Regulatory Process, Manufacturing Considerations

(99% Neutral) MOLECULIN BIOTECH, INC. (MBRX) Announces Update on Collaboration with MOLECULIN BIOTECH, INC

Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States